Literature DB >> 21383247

Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells.

Clare A Notley1, Mark A Brown, Graham P Wright, Michael R Ehrenstein.   

Abstract

The clearance of dying cells is vital for re-establishing tolerance during inflammation and has potent immunoregulatory consequences. Because natural IgM plays a key role in the removal of apoptotic cells, we investigated whether the immune modulatory properties of apoptotic cells depended on its presence. Using an Ab-independent, Ag-induced model of inflammatory arthritis, we tested whether natural IgM is essential for the arthritis-suppressing properties of apoptotic cells. Whereas administration of apoptotic cells reduced joint inflammation and damage in normal mice accompanied by suppression of the Th17 response, no protection was afforded in secreted IgM-deficient (Sμ(-)) mice. The enhanced production of IL-10 by T cells from draining lymph nodes and splenic marginal zone B cells, driven by the infusion of apoptotic cells, was abrogated in the absence of natural IgM. Apoptotic cells were present shortly after administration in the splenic marginal zone, but their removal was substantially delayed in the absence of natural IgM. Incubation of apoptotic cells with natural IgM in vitro restored their arthritis-suppressing properties in Sμ(-) mice. Moreover, these IgM-coated apoptotic cells were cleared rapidly after injection from the spleens of Sμ(-) mice. Our results demonstrate that natural IgM is a critical factor in a chain of events triggered by the administration of apoptotic cells that promote IL-10-secreting B and T cells and restrain the development of inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383247     DOI: 10.4049/jimmunol.1003021

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

Review 1.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

2.  TIM-1 signaling is required for maintenance and induction of regulatory B cells.

Authors:  M Y Yeung; Q Ding; C R Brooks; S Xiao; C J Workman; D A A Vignali; T Ueno; R F Padera; V K Kuchroo; N Najafian; D M Rothstein
Journal:  Am J Transplant       Date:  2015-02-02       Impact factor: 8.086

3.  A revival for immunoglobulin therapy in septic shock?

Authors:  Julien Textoris; Thierry Calandra; Frédéric Pène
Journal:  Intensive Care Med       Date:  2014-10-30       Impact factor: 17.440

Review 4.  Protective autoantibodies in the rheumatic diseases: lessons for therapy.

Authors:  Gregg J Silverman; Jaya Vas; Caroline Grönwall
Journal:  Nat Rev Rheumatol       Date:  2013-03-19       Impact factor: 20.543

5.  Antigen-driven induction of polyreactive IgM during intracellular bacterial infection.

Authors:  Derek D Jones; Gregory A DeIulio; Gary M Winslow
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

6.  Healthy Donor Polyclonal IgMs Diminish B-Lymphocyte Autoreactivity, Enhance Regulatory T-Cell Generation, and Reverse Type 1 Diabetes in NOD Mice.

Authors:  Christopher S Wilson; Preeti Chhabra; Andrew F Marshall; Caleigh V Morr; Blair T Stocks; Emilee M Hoopes; Rachel H Bonami; Greg Poffenberger; Kenneth L Brayman; Daniel J Moore
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

7.  A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells.

Authors:  Katherine Miles; Jonathan Heaney; Zaneta Sibinska; Donald Salter; John Savill; David Gray; Mohini Gray
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-29       Impact factor: 11.205

Review 8.  Natural Antibodies: from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis.

Authors:  Mohan S Maddur; Sébastien Lacroix-Desmazes; Jordan D Dimitrov; Michel D Kazatchkine; Jagadeesh Bayry; Srini V Kaveri
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

Review 9.  Germinal centers and autoimmune disease in humans and mice.

Authors:  Anthony L DeFranco
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

10.  Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.

Authors:  Katja Aviszus; Megan K L Macleod; Greg A Kirchenbaum; Thiago O Detanico; Ryan A Heiser; James B St Clair; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.